Maribel Soto-Nava

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Dna Methylation

Inflammatory Response

Respiratory Syndrome Coronavirus

Top Venues

Virology journal

This page only lists publications with an associated author ORCID identifier.

Publications

Mario Perez-Medina, Jose S Lopez-Gonzalez, Jesus J Benito-Lopez, Santiago Ávila-Ríos, Maribel Soto-Nava, Margarita Matias-Florentino, Alfonso Méndez-Tenorio, Miriam Galicia-Velasco, Rodolfo Chavez-Dominguez, Sergio E Meza-Toledo, Dolores Aguilar-Cazares
Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell Lines. Cancers 16 (13) (2024)
Mario Perez-Medina, Jose S Lopez-Gonzalez, Jesus J Benito-Lopez, Santiago Ávila-Ríos, Maribel Soto-Nava, Margarita Matias-Florentino, Alfonso Méndez-Tenorio, Miriam Galicia-Velasco, Rodolfo Chavez-Dominguez, Sergio E Meza-Toledo, Dolores Aguilar-Cazares
Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell Lines. Cancers 16 (13) (2024)
Maribel Soto-Nava, Vanessa Dávila-Conn, Juan P Venancio-Rocha, Pedro García-Esparza, Daniela Tapia-Trejo, Ramón Hernández-Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Avila-Ríos
SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City. Virology journal 20 (1) (2023)
Maribel Soto-Nava, Vanessa Dávila-Conn, Juan P Venancio-Rocha, Pedro García-Esparza, Daniela Tapia-Trejo, Ramón Hernández-Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Avila-Ríos
SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City. Virology journal 20 (1) (2023)
Maribel Soto-Nava, Vanessa Dávila-Conn, Juan P Venancio-Rocha, Pedro García-Esparza, Daniela Tapia-Trejo, Ramón Hernández-Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Avila-Ríos
SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City. Virology journal 20 (1) (2023)
Ricardo Serna-Muñoz, Alejandra Hernández-Terán, Maribel Soto-Nava, Daniela Tapia-Trejo, Santiago Ávila-Ríos, Fidencio Mejía-Nepomuceno, Emma García, Manuel de Jesus Castillejos Lopez, Anjarath Lorena Higuera-Iglesias, Arnoldo Aquino-Galvez, Ireri Thirion-Romero, Rogelio Pérez-Padilla, José Leopoldo Aguilar-Faisal, Joel Armando Vazquez-Perez
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes. Vaccines 10 (12) (2022)
Ricardo Serna-Muñoz, Alejandra Hernández-Terán, Maribel Soto-Nava, Daniela Tapia-Trejo, Santiago Ávila-Ríos, Fidencio Mejía-Nepomuceno, Emma García, Manuel de Jesus Castillejos Lopez, Anjarath Lorena Higuera-Iglesias, Arnoldo Aquino-Galvez, Ireri Thirion-Romero, Rogelio Pérez-Padilla, José Leopoldo Aguilar-Faisal, Joel Armando Vazquez-Perez
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes. Vaccines 10 (12) (2022)
Ricardo Serna-Muñoz, Alejandra Hernández-Terán, Maribel Soto-Nava, Daniela Tapia-Trejo, Santiago Ávila-Ríos, Fidencio Mejía-Nepomuceno, Emma García, Manuel de Jesus Castillejos Lopez, Anjarath Lorena Higuera-Iglesias, Arnoldo Aquino-Galvez, Ireri Thirion-Romero, Rogelio Pérez-Padilla, José Leopoldo Aguilar-Faisal, Joel Armando Vazquez-Perez
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes. Vaccines 10 (12) (2022)
Ricardo Serna-Muñoz, Alejandra Hernández-Terán, Maribel Soto-Nava, Daniela Tapia-Trejo, Santiago Ávila-Ríos, Fidencio Mejía-Nepomuceno, Emma García, Manuel de Jesus Castillejos Lopez, Anjarath Lorena Higuera-Iglesias, Arnoldo Aquino-Galvez, Ireri Thirion-Romero, Rogelio Pérez-Padilla, José Leopoldo Aguilar-Faisal, Joel Armando Vazquez-Perez
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes. Vaccines 10 (12) (2022)